全文获取类型
收费全文 | 4494篇 |
免费 | 253篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 52篇 |
妇产科学 | 77篇 |
基础医学 | 733篇 |
口腔科学 | 229篇 |
临床医学 | 452篇 |
内科学 | 938篇 |
皮肤病学 | 40篇 |
神经病学 | 442篇 |
特种医学 | 118篇 |
外科学 | 622篇 |
综合类 | 27篇 |
一般理论 | 14篇 |
预防医学 | 277篇 |
眼科学 | 29篇 |
药学 | 416篇 |
中国医学 | 5篇 |
肿瘤学 | 258篇 |
出版年
2023年 | 17篇 |
2022年 | 24篇 |
2021年 | 82篇 |
2020年 | 56篇 |
2019年 | 84篇 |
2018年 | 121篇 |
2017年 | 99篇 |
2016年 | 89篇 |
2015年 | 85篇 |
2014年 | 140篇 |
2013年 | 186篇 |
2012年 | 300篇 |
2011年 | 330篇 |
2010年 | 176篇 |
2009年 | 181篇 |
2008年 | 288篇 |
2007年 | 276篇 |
2006年 | 284篇 |
2005年 | 289篇 |
2004年 | 242篇 |
2003年 | 248篇 |
2002年 | 216篇 |
2001年 | 55篇 |
2000年 | 46篇 |
1999年 | 53篇 |
1998年 | 43篇 |
1997年 | 63篇 |
1996年 | 37篇 |
1995年 | 40篇 |
1994年 | 34篇 |
1993年 | 34篇 |
1992年 | 22篇 |
1991年 | 25篇 |
1990年 | 14篇 |
1989年 | 21篇 |
1988年 | 33篇 |
1987年 | 27篇 |
1986年 | 20篇 |
1985年 | 29篇 |
1984年 | 20篇 |
1983年 | 15篇 |
1982年 | 14篇 |
1981年 | 13篇 |
1980年 | 13篇 |
1979年 | 15篇 |
1977年 | 18篇 |
1976年 | 20篇 |
1972年 | 14篇 |
1971年 | 14篇 |
1969年 | 12篇 |
排序方式: 共有4759条查询结果,搜索用时 31 毫秒
111.
Albert Propst M.D. Theresa Propst M.D. Peter Waldenberger M.D. Wolfgang Vogel M.D. Gert Judmaier M.D. 《The American journal of gastroenterology》1995,90(8):1345-1346
Hepatoccllular adenomatosis is characterized by the presence of numerous (arbitrarily > 10) adenomas within an otherwise normal liver without a history of glycogen storage disease or steroid hormone therapy. Although the disease is rare, its importance lies in its tendency to produce symptoms such as abdominal pain and its potential for abdominal hemorrhages. However, the prognosis of hepatocellular adenomatosis remains uncertain. Here we describe the ease of a -40-yr-old female with hepatoccllular adenomatosis without evidence of serious complications, who was observed over a period of 11 yr. 相似文献
112.
113.
114.
Geertje M. de Boer Gert-Jan Braunstahl Esmee K. van der Ploeg Cathelijne M. van Zelst Alie van Bruggen Guido Epping Menno van Nimwegen Gert Verhoeven Erwin Birnie Bianca M. Boxma-de Klerk Marjolein J. W. de Bruijn Ralph Stadhouders Rudi W. Hendriks Gerdien A. Tramper-Stranders 《Clinical and experimental allergy》2021,51(9):1172-1184
115.
Skeaff CM Thoma C Mann J Chisholm A Williams S Richmond K 《Nutrition, metabolism, and cardiovascular diseases : NMCD》2005,15(5):337-344
BACKGROUND AND AIM: The aim of the study was to determine the effects on plasma cholesterol of replacing a plant sterol-enriched fat spread with carbohydrate-rich foods relative to a diet high in saturated fat. METHODS AND RESULTS: Twenty-nine men and women, from the general community, with mean age (SD) 48 (14)y, body mass index 29.0 (6.2)kg/m(2), and plasma total cholesterol concentration 6.48 (0.97)mmol/L completed the randomised, crossover dietary intervention. There were three diets: New Zealand diet (NZ diet) high in total (34%kJ) and saturated (15%kJ) fat, a cholesterol-lowering fibre-rich diet reduced in total (30%kJ) and saturated fat (8%kJ) but including a plant sterol spread (PS diet), and the same cholesterol-lowering diet with the plant sterol spread isocalorically replaced with carbohydrate (CHO diet); total fat, 26%kJ; saturated fat 7%kJ. All foods were provided and each diet was followed for four weeks. Mean (SD) plasma low-density lipoprotein cholesterol concentration declined from 4.68 (0.91)mmol/L on the high saturated fat diet to 4.12 (0.83)mmol/L (P<0.001) on the carbohydrate diet and 3.76 (0.84)mmol/L (P<0.001) on the plant sterol diet. The 20% decrease on the plant sterol diet was significantly greater (P<0.001) than the 12% decrease on the carbohydrate diet. Relative to the NZ diet, mean (95% CI) plasma high-density lipoprotein cholesterol concentration changed by -0.11 (-0.16, -0.06)mmol/L on the CHO diet but was not different at the end of the PS diet, -0.03 (-0.09, 0.02). CONCLUSION: Including a plant sterol-enriched fat spread in a cholesterol-lowering diet produces a more favourable plasma lipid profile than the same diet made lower in total and saturated fat by replacing the spread with carbohydrate-rich foods. 相似文献
116.
117.
118.
Daniel E. Mckee Donald H. Lalonde Achilleas Thoma Lisa Dickson 《Hand (New York, N.Y.)》2015,10(4):613-615
Background
In our experience, for all surgeries in the hand, the optimal epinephrine effect from local anesthesia—producing maximal vasoconstriction and visualization—is achieved by waiting significantly longer than the traditionally quoted 7 min from the time of injection.Methods
In this prospective comparative study, healthy patients undergoing unilateral carpal tunnel surgery waited either 7 min or roughly 30 min, between the time of injection of 1 % lidocaine with 1:100,000 epinephrine and the time of incision. A standardized incision was made through dermis and into the subcutaneous tissue followed by exactly 60 s of measuring the quantity of blood loss using sterile micropipettes.Results
There was a statistically significant reduction in the mean quantity of bleeding in the group that waited roughly 30 min after injection and before incision compared to the group that waited only 7 min (95 % confidence intervals of 0.06 + −0.03 ml/cm of incision, compared to 0.17 + −0.08 ml/cm, respectively) (P = 0.03).Conclusions
Waiting roughly 30 min after injection of local anesthesia with epinephrine as oppose to the traditionally taught 7 min, achieves an optimal epinephrine effect and vasoconstriction. In the hand, this will result in roughly a threefold reduction in bleeding—making wide awake local anesthesia without tourniquet (WALANT) possible. This knowledge has allowed our team to expand the hand procedures that we can offer using WALANT. The benefits of WALANT hand surgery include reduced cost and waste, improved patient safety, and the ability to perform active intraoperative movement examinations. 相似文献119.
120.
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. 总被引:4,自引:0,他引:4
Christian F Opitz Roland Wensel J?rg Winkler Michael Halank Leonhard Bruch Franz-Xaver Kleber Gert H?ffken Stefan D Anker Abdissa Negassa Stephan B Felix Roland Hetzer Ralf Ewert 《European heart journal》2005,26(18):1895-1902
AIMS: To describe the long-term clinical efficacy of inhaled iloprost as first-line vasodilator mono-therapy in patients with idiopathic pulmonary arterial hypertension (IPAH). METHODS AND RESULTS: Seventy-six IPAH patients were prospectively identified and treated with inhaled iloprost. Clinical, haemodynamic, and exercise parameters were obtained at baseline, after 3 and 12 months of therapy and yearly thereafter. Four endpoints were prospectively defined as follows: (i) death, (ii) transplantation, (iii) switch to intravenous (i.v.) therapy, or (iv) addition of or switch to other active oral therapy. During follow-up (535+/-61 days), 11 patients died, six were transplanted, 25 were switched to i.v. prostanoids, 16 received additional or other oral therapy, and 12 patients discontinued iloprost inhalation for other reasons. Event-free survival at 3, 12, 24, 36, 48, and 60 months was 81, 53, 29, 20, 17 and 13%, respectively. Among haemodynamic and exercise parameters, mixed venous oxygen saturation (P<0.001), right atrial pressure (P<0.001), and peak oxygen uptake (P=0.002) were associated with event-free survival. CONCLUSION: In this study, only a minority of patients could be stabilized with inhaled iloprost mono-therapy during a follow-up period of up to 5 years. In the presence of multiple treatment options, chronic iloprost inhalation as mono-therapy appears to have a limited role. 相似文献